Does atypical antipsychotic medication improve executive function in schizophrenia? [2]

International Journal of Neuropsychopharmacology

Volumn 9, Issue 5, 2006, Pages 629-630

  Collie, Alex ^a,b,c   Maruff, Paul ^b,d   Snyder, Peter J ^e  

^a CogState Ltd ^*  (Australia)

^b University of Melbourne ^*  (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE;

COGNITION; GOLD STANDARD; HUMAN; LETTER; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HUMANS; PROBLEM SOLVING; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33750200621     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007012     Document Type: Letter

References (7)

1. Basso MR, Bornstein RA, Lang JM (1999). Practice effects of commonly used measures of executive function across twelve months. Clinical Neuropsychologist 13, 283-292.
2. Bender S, Dittmann-Balcar A, Schall U, Wolstein J, Klimke A, Riedel M, Vorbach EU, Kühn KU, Lambert M, Dittmann RW, Naber D (2006). Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine. International Journal of Neuropsychopharmacology 9, 135-145.
3. Collie A, Maruff P, Darby DG, McStephen M (2003). The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. Journal of the International Neuropsychological Society 9, 419-428.
4. Harvey PD, Bowie CR, Loebel A (2006). Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. Journal of Neuropsychiatry and Clinical Neuroscience 18, 54-63.
5. McCaffrey RJ, Duff K, Westervelt HJ (2000). Practitioner's Guide to Evaluating Change with Neuropsychological Assessment Instruments. New York: Kluwer Academic/Plenum Publishers.
6. Smith EE, Jonides J (1999). Storage and executive processes in the frontal lobes. Science 283, 1657-1661.
7. Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P (2005). A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Human Psychopharmacology 20, 263-273.